Research: Bone-density tests unnecessary for women on osteoporosis therapy

06/25/2009 | Yahoo!

Australian researchers say it may not be necessary -- and even could be misleading -- to monitor bone density in older women in the first three years after they begin a drug regimen to prevent osteoporosis. Their study of more than 6,000 postmenopausal women found that after three years of treatment, 97.5% had at least a modest increase in bone density, with little variation in the treatment's effect on the women.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
Bend, OR
Clinical Appeals RN
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ